相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways
Yuan Zhang et al.
AGING-US (2020)
Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks
Arpan De et al.
CLINICAL & EXPERIMENTAL METASTASIS (2020)
A Non-canonical Function of BMAL1 Metabolically Limits Obesity-Promoted Triple-Negative Breast Cancer
Cassandra A. Ramos et al.
ISCIENCE (2020)
FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis
Ran Wei et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
State Variation in Early-Onset Colorectal Cancer in the United States, 1995-2015
Rebecca L. Siegel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A
Elke Burgermeister et al.
EBIOMEDICINE (2019)
Medicine in the Fourth Dimension
Christopher R. Cederroth et al.
CELL METABOLISM (2019)
BMAL1 but not CLOCK is associated with monochromatic green light-induced circadian rhythm of melatonin in chick pinealocytes
Shuhui Ma et al.
ENDOCRINE CONNECTIONS (2019)
Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment
Gabriele Sulli et al.
TRENDS IN CANCER (2019)
Dosing time dependent in vitro pharmacodynamics of Everolimus despite a defective circadian clock
Yuan Zhang et al.
CELL CYCLE (2018)
The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer
Luise Fuhr et al.
EBIOMEDICINE (2018)
A Systems-Level Analysis Reveals Circadian Regulation of Splicing in Colorectal Cancer
Rukeia El-Athman et al.
EBIOMEDICINE (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Opposite Carcinogenic Effects of Circadian Clock Gene BMAL1
Tuba Korkmaz et al.
SCIENTIFIC REPORTS (2018)
Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma
Qingming Tang et al.
CANCER RESEARCH (2017)
Transcriptional architecture of the mammalian circadian clock
Joseph S. Takahashi
NATURE REVIEWS GENETICS (2017)
Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer
Yaping Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis
Yankun Liu et al.
CELL DEATH & DISEASE (2017)
Transforming growth factor-β1 contributes to oxaliplatin resistance in colorectal cancer via epithelial to mesenchymal transition
Liang Mao et al.
ONCOLOGY LETTERS (2017)
The regulation of β-catenin activity and function in cancer: therapeutic opportunities
Shuang Shang et al.
ONCOTARGET (2017)
The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway
Weiliang Jiang et al.
CANCER LETTERS (2016)
Twist mediates an aggressive phenotype in human colorectal cancer cells
Jun-Jian Deng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy
Robert Dallmann et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Signal Transduction Pathways of EMT Induced by TGF-, SHH, and WNT and Their Crosstalks
Jingyu Zhang et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Mobilization of epithelial mesenchymal transition genes distinguishes active from inactive lesional tissue in patients with ulcerative colitis
Xinmei Zhao et al.
HUMAN MOLECULAR GENETICS (2015)
A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites
Yan Zhang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2015)
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
Eva Martinez-Balibrea et al.
MOLECULAR CANCER THERAPEUTICS (2015)
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
Wenting Xu et al.
CELL ADHESION & MIGRATION (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer
Zhao-lei Zeng et al.
CLINICAL CANCER RESEARCH (2014)
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Maria Angelica Cortez et al.
MOLECULAR THERAPY (2014)
Ras-Mediated Deregulation of the Circadian Clock in Cancer
Angela Relogio et al.
PLOS GENETICS (2014)
Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy
Wendy W. Hwang-Verslues et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
Ester Sanchez-Tillo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown
Jun Ye et al.
MOLECULAR MEDICINE REPORTS (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Phase I – II study to assess the feasibility and activity of the triple combination of 5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11) administered by chronomodulated infusion for the treatment of advanced colorectal cancer. Final report of the BE-1603 study
C. Focan et al.
PATHOLOGIE BIOLOGIE (2012)
RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization
Larissa Lordier et al.
NATURE COMMUNICATIONS (2012)
E-Cadherin/beta-Catenin Complex and the Epithelial Barrier
Xinrui Tian et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer
Takashi Oshima et al.
ONCOLOGY REPORTS (2011)
Circadian Timing in Cancer Treatments
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway
Shreyas Das et al.
BMC CELL BIOLOGY (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
FactoMineR: An R package for multivariate analysis
Sebastien Le et al.
JOURNAL OF STATISTICAL SOFTWARE (2008)
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
A. Jeanes et al.
ONCOGENE (2008)
Carcinogenicity of shift-work, painting, and fire-fighting
Kurt Straif et al.
LANCET ONCOLOGY (2007)
Role of APAF-I, E-cadherin and peritumoural lymphocytic infiltration in turnour budding in colorectal cancer
I. Zlobec et al.
JOURNAL OF PATHOLOGY (2007)
Prognostic significance of the wnt signalling pathway molecules APC, β-catenin and E-cadherin in colorectal cancer -: a tissue microarray-based analysis
A. Lugli et al.
HISTOPATHOLOGY (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The circadian clock: Pacemaker and tumour suppressor
LN Fu et al.
NATURE REVIEWS CANCER (2003)
Genetic programs of epithelial cell plasticity directed by transforming growth factor-β
J Zavadil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mop3 is an essential component of the master circadian pacemaker in mammals
MK Bunger et al.
CELL (2000)
Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover
BR Henderson
NATURE CELL BIOLOGY (2000)
分享论文
